Download presentation
Presentation is loading. Please wait.
Published byΚαλλιστράτης Αθανασίου Modified over 5 years ago
1
Volume 74, Issue 5, Pages 571-576 (September 2008)
Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease Linda F. Fried Kidney International Volume 74, Issue 5, Pages (September 2008) DOI: /ki Copyright © 2008 International Society of Nephrology Terms and Conditions
2
Figure 1 Mevalonic acid pathway and implications for kidney disease. ECM=extracellular matrix. Data from Liao,37,38 Kim et al.,39 Rikitake and Liao,40 Vecchione et al.,41 Gojo et al.,42 Toblli et al.,43 Xu et al.,44 and McTaggart.45 Kidney International , DOI: ( /ki ) Copyright © 2008 International Society of Nephrology Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.